Nasdaq-listed shares of Quantum BioPharma (QNTM) surged 15% on Wednesday after the companysaid its licensee, Celly Nutrition ...

The Company issued 2,420 Debenture Units (as defined in the December 5 NR, as amended by the March 7 Toronto, Ontario--(Newsfile Corp. - March 30, 2025) - Quantum BioPharma Ltd. (NASDAQ ...

In addition, the Company has begun development of a formulation for rekvry™ – an alcohol misuse treatment for emergency and hospital settings. The Company believes that rekvry™ fulfills an unmet need ...

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

The company shed its FSD Pharma identity last year as it positions its alcohol metabolism and multiple sclerosis treatments ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and ...

Quantum BioPharma (QNTM) announces the appointment of Terry Lynch to its board of directors. Lynch will be replacing Dr. Sanjiv Chopra, who has ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), has reported its financial and operational results for the ...

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a ...

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”) is pleased to announ Quantum Biopharma ...

Morningstar brands and products Company Portfolio ...